In a recent article, we wrote about an Israeli 3D printing startup that’s developing their flagship machine “capable of micron-resolution printing, with the capability to print thousands of p...
It’s hard to say just how many publicly traded stocks we’ve covered so far on Nanalyze, but we’d guess that around 40% of our articles involve a publicly traded stock that has some degree o...
At the CB Insights fintech conference that wrapped up recently, an interesting fellow named Michael Novogratz made the remark that “Great bubbles occur around stories that are going to happen�...
If you’re a regular reader of Nanalyze, you’ll know that we’re big fans of the work that Bryan Johnson of Kernel is doing, essentially trying to enable read/write access to the brain. In on...
As each day passes, mankind seems to get dumber and dumber. Squabbling about petty political disagreements, idolizing talent-less “celebrities”, allowing stock promotion scams to run rampant...
We now have 3 genetic engineering companies that have had an IPO and which you can now invest in; Editas Medicine (NASDAQ:EDIT), Intellia Therapeutics (NASDAQ:NTLA), and CRISPR Therapeutics (NASD...
When you read about what some startups are doing these days it seems like you’re reading a sci-fi book. Earlier this year we published an article titled “3 Companies Building Nanorobot Compan...
The big news this past week was something so significant and remarkable that it should have been the topic of conversation at every water cooler everywhere. While Microsoft’s AI bot tweeted out...
About $13 billion dollars in diamonds are produced every year, with 65% of that production coming from Africa. The popularity of a movie called Blood Diamond (2006) brought to light the fact tha...
Synthetic biology is a theme we like to keep tabs on, not just because of the limitless potential this technology offers, but also because it’s just so darn interesting. The most notable pure-p...